Greenwood Capital Associates’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,537
Closed -$867K 216
2022
Q1
$867K Buy
13,537
+20
+0.1% +$1.34K 0.23% 92
2021
Q4
$969K Buy
13,517
+108
+0.8% +$8.21K 0.14% 127
2021
Q3
$957K Buy
13,409
+232
+2% +$18.3K 0.15% 111
2021
Q2
$1.07M Sell
13,177
-33
-0.2% -$2.65K 0.16% 105
2021
Q1
$998K Sell
13,210
-990
-7% -$72.1K 0.16% 108
2020
Q4
$1.07M Buy
14,200
+704
+5% +$45.8K 0.18% 98
2020
Q3
$667K Sell
13,496
-817
-6% -$46.1K 0.13% 102
2020
Q2
$752K Buy
14,313
+579
+4% +$27.5K 0.17% 81
2020
Q1
$483K Sell
13,734
-873
-6% -$51K 0.14% 77
2019
Q4
$1.28M Buy
14,607
+829
+6% +$72.5K 0.27% 74
2019
Q3
$1.17M Buy
13,778
+117
+0.9% +$10.4K 0.28% 73
2019
Q2
$1.44M Buy
13,661
+952
+7% +$95.7K 0.36% 63
2019
Q1
$1.34M Buy
12,709
+8,433
+197% +$847K 0.34% 64
2018
Q4
$358K Buy
4,276
+193
+5% +$17.5K 0.09% 120
2018
Q3
$416K Sell
4,083
-526
-11% -$50.8K 0.09% 122
2018
Q2
$373K Buy
4,609
+516
+13% +$41K 0.09% 124
2018
Q1
$302K Buy
4,093
+924
+29% +$69.1K 0.07% 138
2017
Q4
$223K Buy
+3,169
New +$229K 0.05% 186

Other funds holding NGVT

Greenwood Capital Associates's NGVT Position: Q2 2022 in Review

Greenwood Capital Associates sold out of Ingevity (NGVT) in Q2 2022, closing a stake of 13,537 shares — an estimated $867K sold.

Greenwood Capital Associates first reported a position in NGVT in Q4 2017 and held it in 18 quarters. The position peaked at $1.44M in Q2 2019. 265 funds tracked by Wall St. Rank hold NGVT as of Q2 2022.

  • Greenwood Capital Associates reported no remaining Ingevity position as of Q2 2022 after selling out during the quarter.
  • Greenwood Capital Associates sold 13,537 Ingevity shares in Q2 2022, an estimated $867K.
  • Greenwood Capital Associates first reported a position in Ingevity in Q4 2017 and held it in 18 quarters.
  • Greenwood Capital Associates's Ingevity position peaked at $1.44M in Q2 2019.
  • 265 funds tracked by Wall St. Rank held Ingevity as of Q2 2022.

Based on Greenwood Capital Associates's 13F filing for Q2 2022, filed 10 Aug 2022.